Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population

University Hospital Basel

Status: Completed

Conditions: Prostate Cancer; Localized Carcinoma

Treatments: Diagnostic Test: Stockholm3

Study type: Observational

Funder types: Other

Identifiers

NCT05294627

Stockholm3

Details and patient eligibility

About

The purpose of this study is to collect blood samples to investigate the prognostic performance of the STHLM3 test in a population of Swiss and German men suspected of harbouring prostate cancer based on a combination of elevated PSA levels (e.g. >2.5 ng/ml) and/or pathological digital rectal examination and/or MRI-findings.

Enrollment: 380 patients

Sex: Male

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Planned prostate biopsy due to suspicion of prostate cancer (usually due to a combination of elevated PSA levels [e.g. >2.5 ng/ml] and/or pathological digital rectal examination and/or MRI-findings)
• Written informed consent by the participant

Exclusion criteria

• Severe anemia (Hb <60g/l)
• Previously already established diagnosis of prostate cancer.